Short Interest in Premier Biomedical, Inc. (OTCMKTS:BIEI) Declines By 99.9%

Premier Biomedical, Inc. (OTCMKTS:BIEI) was the recipient of a large decrease in short interest in the month of June. As of June 15th, there was short interest totaling 1,141 shares, a decrease of 99.9% from the May 31st total of 1,184,526 shares. Based on an average daily volume of 39,425,661 shares, the short-interest ratio is currently 0.0 days.

Premier Biomedical Trading Down 18.2%

OTCMKTS BIEI traded down $0.00 during trading hours on Thursday, hitting $0.00. The company had a trading volume of 20,615,121 shares, compared to its average volume of 20,134,438. Premier Biomedical has a fifty-two week low of $0.00 and a fifty-two week high of $0.00.

About Premier Biomedical

Premier Biomedical, Inc, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries.